Widening the door: The evolution of hepatitis C treatment in patients with psychiatric disorders

Authors

  • Cynthia M. A. Geppert M.D, Ph.D., M.P.H.,

    1. Chief Consultation Psychiatry and Ethics, Behavioral Health Care Service, New Mexico Veterans Affairs Health Care System
    2. Assistant Professor Department of Psychiatry and Director of Ethics Education University of New Mexico School of Medicine
    3. Associate Director Religious Studies Program University of New Mexico, Albuquerque, NM
    Search for more papers by this author
  • Sanjeev Arora M.D.

    Corresponding author
    1. Internal Medicine–Gastroenterology, University of New Mexico Health Sciences Center, Albuquerque, NM
    • Internal Medicine–Gastroenterology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131
    Search for more papers by this author

  • See Article on Page 991.

  • Potential conflict of interest: Dr. Arora is on the speaker's bureau of and received grants from Roche Pharmaceuticals and Schering-Pharmaceuticals. He also received grants from Vertex Pharmaceuticals and Valeant Pharmaceuticals.

No abstract is available for this article.

Ancillary